Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
RESEARCH TOOLSreports
MoonLake Immunotherapeutics (MLTX) Ownership Overview
12.86% Insiders
18.25% Mutual Funds
64.15% Other Institutional Investors
0.71% ETFs
4.04% Public Companies and Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 83.10% of the company’s stock is owned by Institutional Investors, 12.86% is owned by Insiders, and 4.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 08, 2024 | xxxxxxxxxxxxx | $9186120 | |
Oct 08, 2024 | xxxxxxxxxxxxx | $100000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $840005 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $11570502 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,078,577 | Insider | 4.85% | 115,816,067 | |
| 3,009,940 | Insider | 4.74% | 113,233,943 | |
| 1,564,479 | Institution | 2.46% | 58,855,700 | |
| 1,287,768 | Insider | 2.03% | 48,445,832 | |
| 1,263,648 | Institution | 1.99% | 47,538,438 | |
| 1,184,000 | Institution | 1.87% | 44,542,080 | |
| 912,310 | Institution | 1.44% | 34,321,102 | |
| 770,822 | Institution | 1.21% | 28,998,324 | |
| 704,819 | Institution | 1.11% | 26,515,291 | |
| 667,176 | Institution | 1.05% | 25,099,161 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,564,479 | Institution | 2.46% | 58,855,700 | |
| 1,263,648 | Institution | 1.99% | 47,538,438 | |
| 1,184,000 | Institution | 1.87% | 44,542,080 | |
| 912,310 | Institution | 1.44% | 34,321,102 | |
| 770,822 | Institution | 1.21% | 28,998,324 | |
| 704,819 | Institution | 1.11% | 26,515,291 | |
| 667,176 | Institution | 1.05% | 25,099,161 | |
| 581,762 | Institution | 0.92% | 21,885,886 | |
| 548,604 | Institution | 0.86% | 20,638,482 | |
| 404,694 | Institution | 0.64% | 15,224,588 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 68,304 | Institution | 0.11% | 2,874,232 | |
| 46,738 | Institution | 0.07% | 1,826,054 | |
| 46,479 | Institution | 0.07% | 1,748,540 | |
| 44,490 | Institution | 0.07% | 1,675,493 | |
| 27,659 | Institution | 0.04% | 1,555,080 | |
| 26,103 | Institution | 0.04% | 981,995 | |
| 23,165 | Institution | 0.04% | 871,467 | |
| 19,350 | Institution | 0.03% | 756,005 | |
| 15,825 | Institution | 0.02% | 665,916 | |
| 15,615 | Institution | 0.02% | 577,599 |
FAQ
Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 64.15% of the company's stock is held by institutional investors, 12.86% is held by insiders, and 4.04% is held by retail investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 64.15% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.04% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
Jorge Santos da Silva owns the most shares of MoonLake Immunotherapeutics (MLTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.